CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Butler John P. CEO and President | Purchase | +69,270 | $1.25 | $87K | 3,367,064 |
| 2019-11-20 | GILMAN STEVEN C Director | Purchase | +5,800 | $3.43 | $20K | 29,731 |
| 2019-11-20 | Smith Cynthia Director | Purchase | +15,000 | $3.52 | $53K | 28,700 |
| 2019-11-20 | Burke Steven Keith SVP, Chief Medical Officer | Purchase | +27,000 | $3.58 | $97K | 37,000 |
| 2019-11-20 | Butler John P. CEO and President | Purchase | +50,000 | $3.44 | $172K | 887,732 |
| 2019-11-20 | ADAMS ADRIAN Director | Purchase | +50,000 | $3.41 | $171K | 63,700 |
Page 1 of 1 · 6 trades